Tanya Siddiqi, MD

Tanya Siddiqi, MD

Tanya Siddiqi, MD

Articles by Tanya Siddiqi, MD

Tanya Siddiqi, MDChronic Lymphocytic Leukemia | March 29, 2024
Dr. Siddiqi shares data from the phase I/II TRANSCEND CLL 004 trial on liso-cel in patients with relapsed or refractory CLL.